###begin article-title 0
Evolution of pharmacologic specificity in the pregnane X receptor
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 485 503 485 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis</italic>
###xml 625 643 625 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis</italic>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 223 226 <span type="species:ncbi:10116">rat</span>
###xml 228 234 <span type="species:ncbi:9986">rabbit</span>
###xml 236 243 <span type="species:ncbi:9031">chicken</span>
###xml 249 258 <span type="species:ncbi:7955">zebrafish</span>
###xml 358 363 <span type="species:ncbi:9606">human</span>
###xml 368 377 <span type="species:ncbi:7955">zebrafish</span>
###xml 464 483 <span type="species:ncbi:8364">Western clawed frog</span>
###xml 485 503 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 625 643 <span type="species:ncbi:7719">Ciona intestinalis</span>
The pregnane X receptor (PXR) shows the highest degree of cross-species sequence diversity of any of the vertebrate nuclear hormone receptors. In this study, we determined the pharmacophores for activation of human, mouse, rat, rabbit, chicken, and zebrafish PXRs, using a common set of sixteen ligands. In addition, we compared in detail the selectivity of human and zebrafish PXRs for steroidal compounds and xenobiotics. The ligand activation properties of the Western clawed frog (Xenopus tropicalis) PXR and that of a putative vitamin D receptor (VDR)/PXR cloned in this study from the chordate invertebrate sea squirt (Ciona intestinalis) were also investigated.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 644 650 644 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 829 830 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 875 893 875 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 49 52 <span type="species:ncbi:10116">rat</span>
###xml 207 216 <span type="species:ncbi:7955">Zebrafish</span>
###xml 357 364 <span type="species:ncbi:9031">Chicken</span>
###xml 499 504 <span type="species:ncbi:9606">human</span>
###xml 509 518 <span type="species:ncbi:7955">zebrafish</span>
###xml 578 587 <span type="species:ncbi:7955">zebrafish</span>
###xml 620 625 <span type="species:ncbi:9606">human</span>
###xml 854 873 <span type="species:ncbi:8364">Western clawed frog</span>
###xml 875 893 <span type="species:ncbi:8364">Xenopus tropicalis</span>
Using a common set of ligands, human, mouse, and rat PXRs share structurally similar pharmacophores consisting of hydrophobic features and widely spaced excluded volumes indicative of large binding pockets. Zebrafish PXR has the most sterically constrained pharmacophore of the PXRs analyzed, suggesting a smaller ligand-binding pocket than the other PXRs. Chicken PXR possesses a symmetrical pharmacophore with four hydrophobes, a hydrogen bond acceptor, as well as excluded volumes. Comparison of human and zebrafish PXRs for a wide range of possible activators revealed that zebrafish PXR is activated by a subset of human PXR agonists. The Ciona VDR/PXR showed low sequence identity to vertebrate VDRs and PXRs in the ligand-binding domain and was preferentially activated by planar xenobiotics including 6-formylindolo-[3,2-b]carbazole. Lastly, the Western clawed frog (Xenopus tropicalis) PXR was insensitive to vitamins and steroidal compounds and was activated only by benzoates.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 191 196 <span type="species:ncbi:9606">human</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
###xml 209 212 <span type="species:ncbi:10116">rat</span>
###xml 294 313 <span type="species:ncbi:8364">Western clawed frog</span>
###xml 343 362 <span type="species:ncbi:8355">African clawed frog</span>
In contrast to other nuclear hormone receptors, PXRs show significant differences in ligand specificity across species. By pharmacophore analysis, certain PXRs share similar features such as human, mouse, and rat PXRs, suggesting overlap of function and perhaps common evolutionary forces. The Western clawed frog PXR, like that described for African clawed frog PXRs, has diverged considerably in ligand selectivity from fish, bird, and mammalian PXRs.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 394 399 <span type="species:ncbi:9606">human</span>
The pregnane X receptor (PXR; NR1I2; also known as steroid and xenobiotic receptor) is a member of the nuclear hormone receptor (NR) superfamily [1,2]. PXR functions as a ligand-activated transcription factor and regulates the metabolism, transport, and excretion of exogenous compounds, steroid hormones, vitamins, bile salts, and xenobiotics. A remarkably diverse array of compounds activate human PXR, although generally only at micromolar concentrations (less commonly at high nanomolar concentrations), consistent with a hypothesized function of PXR as a toxic compound sensor [3,4] (see Figure 1 for chemical structures of some PXR activators).
###end p 9
###begin p 10
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chemical structures of PXR activators</bold>
###xml 234 235 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 589 593 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 879 885 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans </italic>
Chemical structures of PXR activators. Chemical structures of the PXR activators 5beta-pregnane-3,20-dione, 5alpha-androstan-3alpha-ol, 5beta-lithocholic acid, 5alpha-cyprinol 27-sulfate, 3-aminoethylbenzoate, and 6-formylindolo-[3,2-b]-carbozole. The key bond positions are numbered for the steroids and bile salts, and the lettering of the steroidal rings is indicated for pregnanedione and lithocholic acid. The structure to the right of lithocholic acid illustrates the most stable orientation of the A, B, and C steroid rings for 5beta-bile salts (like lithocholic acid) with the A/B cis configuration (referring to the relative orientation of the hydrogen atom substituents on carbon atoms 5 and 10). The structure to the right of 5alpha-cyprinol sulfate shows the most stable orientation of 5alpha-bile salts (like 5alpha-cyprinol sulfate) that prefentially adopt the A/B trans configuration.
###end p 10
###begin p 11
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 113 126 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 135 138 <span type="species:ncbi:10116">rat</span>
###xml 140 146 <span type="species:ncbi:9986">rabbit</span>
###xml 148 151 <span type="species:ncbi:9615">dog</span>
###xml 153 156 <span type="species:ncbi:9823">pig</span>
###xml 158 165 <span type="species:ncbi:9031">chicken</span>
###xml 177 186 <span type="species:ncbi:7955">zebrafish</span>
PXR genes have been cloned and functionally characterized from a variety of vertebrate species, including human, rhesus monkey, mouse, rat, rabbit, dog, pig, chicken, frog, and zebrafish [1,4-12]. Like other NRs, PXRs have a modular structure with two major domains: an N-terminal DNA-binding domain (DBD) and a larger C-terminal ligand-binding domain (LBD). The PXR LBD is unusually divergent across species, compared to other NRs, with only 50% sequence identity between mammalian and non-mammalian PXR sequences; other NRs tend to have corresponding sequence identities at least 10-20% higher [12,13]. Even the PXR DBD, which is more highly conserved across species than the LBD, shows more cross-species sequence diversity than other NRs [12-16]. A detailed phylogenetic analysis of the entire vertebrate NR superfamily demonstrated evidence of positive evolutionary selection for the LBD of PXRs [17].
###end p 11
###begin p 12
###xml 263 272 263 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 65 74 <span type="species:ncbi:7955">zebrafish</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 154 157 <span type="species:ncbi:10116">rat</span>
###xml 159 165 <span type="species:ncbi:9986">rabbit</span>
###xml 167 174 <span type="species:ncbi:9031">chicken</span>
###xml 186 195 <span type="species:ncbi:7955">zebrafish</span>
In this study, we compare in detail the selectivity of human and zebrafish PXRs for steroid hormones and related compounds. We also compare human, mouse, rat, rabbit, chicken, frog, and zebrafish PXRs with a set of common compounds that activate most PXRs. These in vitro data are used to develop pharmacophore models to capture the essential structural and chemical features of activators of these PXRs (pharmacophore models summarize the key features important for biological activity). Commonly used features in pharmacophore models include hydrophobic, hydrogen bond acceptor, hydrogen bond donor, and excluded volumes (areas where atoms are not allowed, e.g., due to steric overlap with receptor amino acid residues).
###end p 12
###begin p 13
###xml 201 220 201 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 519 542 519 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 561 584 561 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans </italic>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 697 726 697 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Strongylocentrotus purpuratus</italic>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1348 1349 1348 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1597 1599 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1844 1845 1844 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1875 1894 1875 1894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 1933 1939 1933 1939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 1975 1993 1975 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis</italic>
###xml 2180 2182 2180 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 201 219 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 519 542 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 561 583 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 678 695 <span type="species:ncbi:7668">purple sea urchin</span>
###xml 697 726 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
###xml 1299 1306 <span type="species:ncbi:9031">chicken</span>
###xml 1582 1589 <span type="species:ncbi:71164">hagfish</span>
###xml 1875 1893 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 1975 1993 <span type="species:ncbi:7719">Ciona intestinalis</span>
We sought to probe the distant evolutionary history of PXR and the related vitamin D receptor (VDR; NR1I1) by studying an invertebrate NR1I-like receptor. The draft genome of the chordate invertebrate Ciona intestinalis (sea squirt; a urochordate) revealed a single gene [GenBank: ] with close sequence similarity to the vertebrate VDRs, PXRs, and constitutive androstane receptors (CARs, NR1I3) [18,19] (see Additional file 1 for sequence alignment). NR1I-like genes were also detected in the genomes of the fruitfly (Drosophila melanogaster) and the nematode Caenorhabditis elegans [20], although these genes have yet to be functionally characterized. The draft genome of the purple sea urchin (Strongylocentrotus purpuratus) revealed several putative NR1H-like genes but no NR1I-like genes [21]. The early evolutionary history of the NR1I subfamily (VDR, PXR, CAR) in vertebrates is not completely clear, but one hypothesis is that a single ancestral 'VDR/PXR' gene duplicated, with the two genes then diverging into distinct VDRs and PXRs, both of which are currently found in both mammalian and non-mammalian species [22]. We follow the convention of referring to the non-mammalian PXR/CAR-like genes as PXRs [12], although it is not clear whether the function of the single gene in fishes and chicken is more similar to mammalian CAR or PXR [9,10]. The duplication of a single VDR/PXR gene into two different genes may have occurred during a complex series of gene duplications that are thought to have occurred in early vertebrate evolution, based on analysis of lamprey and hagfish genes [23]. Later in vertebrate evolution (probably early on in or before the evolution of mammals), a single PXR-like ancestral gene then duplicated with subsequent divergence into the separate PXR and CAR genes found in all mammals sequenced thus far [9]. For simplicity, the single Ciona intestinalis NR1I-like gene will be referred to as 'Ciona VDR/PXR'. One advantage of studying Ciona intestinalis, in addition to the genome project data available, is that this animal is a member of Urochordata, a subphylum now thought to contain the closest extant relatives of modern vertebrates [24].
###end p 13
###begin p 14
###xml 27 46 27 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 530 536 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 707 713 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 940 946 940 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 27 45 <span type="species:ncbi:7719">Ciona intestinalis</span>
From the Ghost database of Ciona intestinalis Genomic and cDNA Resources [25], cDNA clone IDs ciem829d05 and cilv048e18 correspond to the Ciona VDR/PXR. Based on the expressed sequence tag counts, these cDNAs show highest expression in the larvae and juvenile life stages and lower expression in eggs, cleaving embryos, young adults, and mature adults. For adult animals, expression was seen in gonadal tissue and blood cells. Although invertebrates are not known to produce and utilize vitamin D pathways, we speculated that the Ciona VDR/PXR may bind ligands structurally similar to vitamin D, based on the subsequent evolutionary development and ligand preferences of vertebrate VDRs. Alternatively, the Ciona VDR/PXR may function more like vertebrate PXRs, and assist in protection from toxic levels of endogenous and/or exogenous compounds, in which case it might bind a diverse array of ligands. We therefore cloned and expressed the Ciona VDR/PXR to determine how similar this receptor is to vertebrate NR1I receptors in terms of activation by ligands.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 15 20 <span type="species:ncbi:9606">human</span>
Selectivity of human PXR
###end title 16
###begin p 17
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 643 648 <span type="species:ncbi:9606">human</span>
We first assessed the ability of a diverse set of compounds to activate human PXR by determining detailed concentration-response curves for activation of human PXR for 25 androstane steroids (Table 1), 11 estrane steroids (Table 1), 29 pregnane steroids (Table 2), 50 bile salts (Additional file 2; some bile salts were previously published [15]), and 50 additional diverse compounds that included xenobiotics and vitamins (Table 3) (see Figure 1 for selected chemical structures of an androstane steroid, a pregnane steroid, two bile salts, and two additional compounds). These activation data further confirm the broad ligand specificity of human PXR, with most compounds only activating at micromolar concentrations.
###end p 17
###begin p 18
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 33 <span type="species:ncbi:7955">zebrafish</span>
Activation of human and zebrafish PXRs by androstane and estrane steroids
###end p 18
###begin p 19
###xml 25 27 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 86 95 <span type="species:ncbi:7955">zebrafish</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 193 202 <span type="species:ncbi:7955">zebrafish</span>
Activities are in -log(EC50), with EC50 in molar units for the activation of human or zebrafish PXR. Efficacy is relative to 10 muM rifampicin (human PXR) or 20 muM 5alpha-androstan-3alpha-ol (zebrafish PXR) which are assigned an efficacy of 1.0. Toxicity is the lowest concentration in micromolar that produced significant toxicity in the HepG2 cells.
###end p 19
###begin p 20
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 33 <span type="species:ncbi:7955">zebrafish</span>
Activation of human and zebrafish PXRs by pregnane steroids and related compounds
###end p 20
###begin p 21
###xml 25 27 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 86 95 <span type="species:ncbi:7955">zebrafish</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 193 202 <span type="species:ncbi:7955">zebrafish</span>
Activities are in -log(EC50), with EC50 in molar units for the activation of human or zebrafish PXR. Efficacy is relative to 10 muM rifampicin (human PXR) or 20 muM 5alpha-androstan-3alpha-ol (zebrafish PXR) which are assigned an efficacy of 1.0. Toxicity is the lowest concentration in micromolar that produced significant toxicity in the HepG2 cells.
###end p 21
###begin p 22
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 33 <span type="species:ncbi:7955">zebrafish</span>
Activation of human and zebrafish PXRs by xenobiotics and vitamins
###end p 22
###begin p 23
###xml 25 27 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 86 95 <span type="species:ncbi:7955">zebrafish</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 193 202 <span type="species:ncbi:7955">zebrafish</span>
Activities are in -log(EC50), with EC50 in molar units for the activation of human or zebrafish PXR. Efficacy is relative to 10 muM rifampicin (human PXR) or 20 muM 5alpha-androstan-3alpha-ol (zebrafish PXR) which are assigned an efficacy of 1.0. Toxicity is the lowest concentration in micromolar that produced significant toxicity in the HepG2 cells.
###end p 23
###begin title 24
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 33 <span type="species:ncbi:7955">zebrafish</span>
Comparison of human and zebrafish PXRs
###end title 24
###begin p 25
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 74 83 <span type="species:ncbi:7955">zebrafish</span>
###xml 250 259 <span type="species:ncbi:7955">zebrafish</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:9606">Human</span>
In two prior studies that compared PXRs from different species, human and zebrafish PXRs were found to share some activating ligands, including pregnanes, androstanes, and a few xenobiotics such as nifedipine and phenobarbital [12,15]. Activation of zebrafish PXR by the much larger set of 165 compounds tested on human PXR was determined in this study, and these two species showed considerable overlap in their ligand specificity (Tables 1, 2, 3, Additional file 2). Human PXR has very broad specificity for steroid hormones and their synthetic intermediates (Figure 2A) albeit mostly at micromolar concentrations likely to exceed typical physiologic concentrations [2,8].
###end p 25
###begin p 26
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PXR activation and steroid pathways</bold>
###xml 802 803 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 96 101 <span type="species:ncbi:9606">Human</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 334 343 <span type="species:ncbi:7955">Zebrafish</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 489 498 <span type="species:ncbi:7955">Zebrafish</span>
###xml 692 701 <span type="species:ncbi:7955">zebrafish</span>
PXR activation and steroid pathways. Steroid pathways typical of vertebrates are indicated. (A) Human PXR is activated by a large number of steroid hormones, although typically at micromolar concentrations. The coloring indicates at which concentrations the various steroids activate human PXR (see key in bottom right of panel). (B) Zebrafish PXR is activated by a smaller number of steroid hormones than human PXR, although there is much overlap between the selectivity of the two PXRs. Zebrafish PXR tends to be more sensitive to steroid hormone activation, at least for the functional assay used in this study. The coloring indicates at which concentrations the various steroids activate zebrafish PXR using the same key as in (A). Abbreviations: dehydroepiandrosterone, DHEA; DHEA sulfate; DHEA SO4; dihydrotesterone, DHT.
###end p 26
###begin p 27
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 711 712 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 717 718 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 910 911 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 916 917 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1041 1043 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1044 1046 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1108 1113 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1130 1133 1085 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1155 1156 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1355 1357 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1358 1360 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1432 1434 1383 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1581 1583 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1584 1586 1528 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1587 1589 1531 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 156 165 <span type="species:ncbi:7955">zebrafish</span>
###xml 239 244 <span type="species:ncbi:9606">Human</span>
###xml 249 258 <span type="species:ncbi:7955">zebrafish</span>
###xml 327 336 <span type="species:ncbi:7955">zebrafish</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 721 730 <span type="species:ncbi:7955">Zebrafish</span>
###xml 980 985 <span type="species:ncbi:9606">human</span>
Zebrafish PXR was activated by far fewer steroid compounds which were essentially a subset of those that activate human PXR (Figure 2B). For both human and zebrafish PXRs, pregnane steroids showed the highest activity (Figure 2, Table 2). Human and zebrafish PXRs showed more differences in regard to bile salt activators with zebrafish PXR being activated by very few of the bile salts tested (Additional file 2). In terms of the evolution of bile salts, human PXR is activated by both evolutionary 'early' bile salts [26-28] (e.g., 27-carbon bile alcohol sulfates such as 5alpha-cholestan-3alpha,7alpha,12alpha,26,27-pentol [cyprinol] 27-sulfate) and 'recent' bile salts (e.g., cholic acid) (Additional files 2 and 3). Zebrafish PXR is activated only by early bile salts, including 5alpha-cyprinol sulfate and 5beta-scymnol (5beta-cholestan-3alpha,7alpha,12alpha,24,26,27-hexol) 27-sulfate (Additional files 2 and 3). The results are consistent with crystallographic studies of human PXR that show a large, flexible ligand-binding pocket [29-34]. This pocket can accommodate bile salts of both 5alpha (A/B trans) and 5beta (A/B cis) orientation (Figure 1), as well as those with differing side-chain lengths and conjugation. This is in contrast to studies of farnesoid X receptors (FXRs; NR1H4) and VDRs, two other NRs that are activated by bile acids [35-38]. In particular, FXRs are antagonized by 5alpha-bile alcohol sulfates [39] while VDRs are essentially only activated by the smallest bile salt, lithocholic acid (5beta-cholan-3alpha-ol-24-oic acid), and its metabolites [38,40,41].
###end p 27
###begin title 28
Pharmacophore models for six PXRs
###end title 28
###begin p 29
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 434 435 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 568 574 565 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A,C,D</xref>
###xml 796 798 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 799 801 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1665 1667 1662 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1714 1716 1711 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 179 188 <span type="species:ncbi:7955">zebrafish</span>
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
###xml 197 200 <span type="species:ncbi:10116">rat</span>
###xml 202 208 <span type="species:ncbi:9986">rabbit</span>
###xml 214 221 <span type="species:ncbi:9031">chicken</span>
###xml 438 443 <span type="species:ncbi:9606">Human</span>
###xml 445 448 <span type="species:ncbi:10116">rat</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 785 790 <span type="species:ncbi:9606">human</span>
###xml 942 947 <span type="species:ncbi:9606">human</span>
###xml 1376 1381 <span type="species:ncbi:9606">human</span>
In a comparative study, we determined concentration-response curves for a common set of 16 compounds (steroids, bile salts, xenobiotics) in a set of PXRs from six species (human, zebrafish, mouse, rat, rabbit, and chicken; Tables 1, 2, 3, 4, Additional file 2). The pharmacophores generated are shown mapped to two of the generally more active ligands, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 5beta-pregnane-3,20-dione (Figure 3). Human, rat, and mouse PXRs showed very similar pharmacophores with 4-5 hydrophobic features and multiple excluded volumes (Figure 3A,C,D). The pharmacophores for these three PXRs all suggest generally large ligand-binding pockets with differences only in positions of the features. It is interesting that compared with previous pharmacophores for human PXR [42-44] which contained 4-5 hydrophobic features and at least 1-2 hydrogen bonding moieties, there are no hydrogen bonding features in the current human PXR pharmacophore. This could be due to the molecules used in the current training set being mostly bile salts and having active and inactive compounds with similar features. As the Catalyst pharmacophore generation method looks for differences between the extremes of activity to describe the features contributing to the pharmacophore, this may represent a limitation of the method. While a single universal pharmacophore for human PXR (and perhaps PXRs from other species) may be impossible due to the size and flexibility of the binding site, it is likely in the current study that the 16 selected molecules may just be a sub-section of the binding pocket. For example, this may be where steroidal compounds fit [33] as modelled previously with a pharmacophore [45]. Therefore, the pharmacophores serve as a novel qualitative method for analysis of PXR ligand specificity across the species.
###end p 29
###begin p 30
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 21 24 <span type="species:ncbi:10116">rat</span>
###xml 26 32 <span type="species:ncbi:9986">rabbit</span>
###xml 38 45 <span type="species:ncbi:9031">chicken</span>
Activation of mouse, rat, rabbit, and chicken PXRs
###end p 30
###begin p 31
###xml 25 27 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 383 388 372 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink">bold </bold>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 84 87 <span type="species:ncbi:10116">rat</span>
###xml 89 95 <span type="species:ncbi:9986">rabbit</span>
###xml 100 107 <span type="species:ncbi:9031">chicken</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 190 193 <span type="species:ncbi:10116">rat</span>
###xml 235 241 <span type="species:ncbi:9986">rabbit</span>
###xml 270 277 <span type="species:ncbi:9031">chicken</span>
Activities are in -log(EC50), with EC50 in molar units for the activation of mouse, rat, rabbit, or chicken PXRs. Efficacy is relative to 20 muM pregnenolone 16alpha-carbonitrile (mouse and rat PXRs), 50 muM 5alpha-pregnan-3,20-dione (rabbit PXR), or 20 muM nifedipine (chicken PXR) which are assigned an efficacy of 1.0. The training set consists of the 16 compounds highlighted in bold font.
###end p 31
###begin p 32
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pharmacophore models of PXR activators</bold>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 101 110 <span type="species:ncbi:7955">zebrafish</span>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 135 138 <span type="species:ncbi:10116">rat</span>
###xml 148 154 <span type="species:ncbi:9986">rabbit</span>
###xml 168 175 <span type="species:ncbi:9031">chicken</span>
###xml 400 406 <span type="species:ncbi:9986">rabbit</span>
Pharmacophore models of PXR activators. Pharmacophore models of PXR activators of (A) human PXR, (B) zebrafish PXR, (C) mouse PXR, (D) rat PXR, (E) rabbit PXR, and (F) chicken PXR. The pharmacophores were generated from the same 16 molecules using Catalyst. The molecules mapped to each pharmacophore are TCDD (green) and 5beta-pregnane-3,20-dione (grey). It should be noted that TCDD is inactive in rabbit PXR and only maps to the hydrophobic features. The pharmacophore features are hydrophobic (cyan), hydrogen bond acceptor and vector (green), and excluded volume (grey).
###end p 32
###begin p 33
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1037 1038 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 234 240 <span type="species:ncbi:9986">Rabbit</span>
###xml 282 291 <span type="species:ncbi:7955">zebrafish</span>
###xml 350 357 <span type="species:ncbi:9031">Chicken</span>
###xml 645 650 <span type="species:ncbi:9606">human</span>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
###xml 659 662 <span type="species:ncbi:10116">rat</span>
###xml 668 674 <span type="species:ncbi:9986">rabbit</span>
###xml 722 729 <span type="species:ncbi:9031">chicken</span>
###xml 734 743 <span type="species:ncbi:7955">zebrafish</span>
###xml 940 947 <span type="species:ncbi:9031">chicken</span>
###xml 952 961 <span type="species:ncbi:7955">zebrafish</span>
Zebrafish PXR showed the most constrained pharmacophore based on the 16 ligands, suggesting a small binding pocket compared with the other PXRs, consisting of 3 hydrophobes, 1 hydrogen bond acceptor, and excluded volumes (Figure 3B). Rabbit PXR had a similar pharmacophore model to zebrafish PXR but no excluded volumes as in the former (Figure 3E). Chicken PXR had a pharmacophore qualitatively different from the other PXRs, with the model indicating a symmetrical array of features that contribute to activity (Figure 3F); it is perhaps noteworthy that this PXR has a smaller 'insert' sequence between helices 1 and 3 of the LBD than that of human, mouse, rat, and rabbit PXRs [9,12]. The pharmacophore models for both chicken and zebrafish PXRs also show a hydrogen bond acceptor not found in the models for PXRs from other species (Figure 3); this hydrogen bonding interaction may contribute to the relatively high activity of TCDD in chicken and zebrafish PXRs. Pharmacophore statistical summaries are presented in Additional file 4.
###end p 33
###begin title 34
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
Unusual pharmacology of Xenopus frog PXRs
###end title 34
###begin p 35
###xml 186 200 186 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 265 275 265 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X. laevis </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 336 346 336 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bone fide </italic>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 466 481 466 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 848 863 848 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
###xml 53 60 <span type="species:ncbi:9031">chicken</span>
###xml 66 75 <span type="species:ncbi:7955">zebrafish</span>
###xml 165 184 <span type="species:ncbi:8355">African clawed frog</span>
###xml 186 200 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 265 274 <span type="species:ncbi:8355">X. laevis</span>
###xml 466 480 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 848 862 <span type="species:ncbi:8355">Xenopus laevis</span>
Whereas other vertebrates such as human, mouse, rat, chicken, and zebrafish have a single PXR gene in their respective genomes, two PXRs have been identified in the African clawed frog (Xenopus laevis) [7,46]. This is likely a consequence of the tetraploidy of the X. laevis genome [47]. The phylogeny confirms that these two genes are bone fide orthlogs to mammalian PXR; however their pharmacology and tissue expression pattern is markedly different [7,46,48,49]. Xenopus laevis PXRs are alternatively termed 'benzoate X receptors' (BXRs) due to their activation by endogenous benzoates (such as 3-aminoethylbenzoate; Figure 1) that play a role in frog development [7]. Similar benzoates have yet to be characterized in other animals, suggesting that these may be unique to amphibians. In addition to PXRs, other gene families show divergence in Xenopus laevis relative to other vertebrates. Per-ARNT-Sim (PAS) proteins such as the aryl hydrocarbon receptor (AHR) nuclear translocator are an example [50].
###end p 35
###begin p 36
###xml 71 89 71 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis</italic>
###xml 335 350 335 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 360 379 360 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 545 560 545 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 586 587 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 590 591 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 592 594 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 50 69 <span type="species:ncbi:8364">Western clawed frog</span>
###xml 71 89 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 335 349 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 360 378 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 465 472 <span type="species:ncbi:9031">chicken</span>
###xml 545 559 <span type="species:ncbi:8355">Xenopus laevis</span>
Our search of the sequenced genome of the related Western clawed frog (Xenopus tropicalis; an animal with a diploid genome) revealed only a single PXR gene. Cloning of the LBD of this PXR from adult female ovary and expression in a GAL4-LBD chimeric construct allowed for determination of ligand specificity. Similar to studies of the Xenopus laevis PXRs, the Xenopus tropicalis PXR was insensitive to steroids, vitamins, and xenobiotics that activate mammalian or chicken PXRs, but was activated by two benzoates described as activators of the Xenopus laevis PXRalpha (Additional File 5) [7,49].
###end p 36
###begin title 37
###xml 18 37 18 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 18 36 <span type="species:ncbi:7719">Ciona intestinalis</span>
Properties of the Ciona intestinalis VDR/PXR
###end title 37
###begin p 38
###xml 18 37 18 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 580 586 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 823 824 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1036 1042 1036 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 1208 1227 1208 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1254 1256 1254 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1257 1259 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 18 36 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 631 642 <span type="species:ncbi:7757">sea lamprey</span>
###xml 647 656 <span type="species:ncbi:7955">zebrafish</span>
###xml 1208 1226 <span type="species:ncbi:7719">Ciona intestinalis</span>
Sequencing of the Ciona intestinalis genome revealed a single gene with similarity to vertebrate NR1I genes VDR, PXR, and CAR [18,19]. We previously reported a preliminary analysis of the Ciona VDR/PXR [51] and now present more detailed data. While the DBD of the Ciona VDR/PXR can be easily aligned to the corresponding sequence of vertebrate VDRs, PXRs, and CARs, alignment of the LBD is difficult in some regions (Additional file 1). As summarized in Table 5, the LBD of Ciona VDR/PXR has low sequence identity to vertebrate VDRs, PXRs, and CARs (17.1%-26.8%). In the DBD, the Ciona VDR/PXR has the highest sequence identity to sea lamprey and zebrafish VDRs (Table 5). The phylogeny of the Ciona VDR/PXR, as inferred by maximum likelihood analysis, does not clearly group this receptor with either VDRs or PXRs (Figure 4). This likely indicates that more sequences are needed, especially additional NR1I receptors (if present) in basal vertebrates (such as Agnatha) and chordate invertebrates. The low sequence identity between the Ciona VDR/PXR and vertebrate VDRs, PXRs, and CARs may be a result of rapid evolution, which has been detected in some gene families (including developmental regulators) in Ciona intestinalis and other tunicates [18,19,52,53].
###end p 38
###begin p 39
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
Sequence Identities of the Ciona VDR/PXR to Other Nuclear Hormone Receptors
###end p 39
###begin p 40
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Maximum likelihood phylogeny of VDRs, PXRs, and CARs</bold>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
Maximum likelihood phylogeny of VDRs, PXRs, and CARs. Maximum likelihood phylogeny of 49 amino acid sequences of VDRs, PXRs, and CARs (see Methods for details of analysis). Numbered branch labels indicate bootstrap percentages. Node labels 'AncR1', 'AncR2', and 'AncR3' indicate ancestral nodes that were reconstructed (see Additional files 7 and 8).
###end p 40
###begin p 41
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 654 655 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 724 730 723 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 900 901 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 908 909 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 939 945 938 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 994 995 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1033 1034 1032 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 1065 1066 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1073 1074 1072 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
The LBD of Ciona VDR/PXR was cloned from cDNA fragments generously provided by Professors Yuji Kohara and Norituki Satoh, and then inserted into the PM2-GAL4 plasmid to create an LBD/GAL4 chimeric receptor. Unlike similar constructs derived from the vertebrate VDRs, this Ciona VDR/PXR was not activated by any vitamin D derivatives, vertebrate bile salts, or steroid hormones (Additional file 5). Screening of a 76-compound nuclear hormone receptor ligand library (BIOMOL International, Plymouth Meeting, PA, USA) revealed that 6-formylindolo-[3,2-b]carbazole activated Ciona VDR/PXR in the low micromolar range (Additional file 5). 6-Formylindolo-[3,2-b]carbazole (20 muM) was chosen as the reference maximal activator of Ciona VDR/PXR. Screening of an additional 90 compounds comprising steroid hormones, vitamins (other than vitamin D), benzoates, and xenobiotics revealed that carbamazepine and n-butyl-p-aminobenzoate also activated Ciona VDR/PXR in the micromolar range (Additional file 5). Interestingly, 6-formylindolo-[3,2-b]carbazole, carbamazepine, and n-butyl-p-aminobenzoate are all planar molecules.
###end p 41
###begin p 42
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
The Catalyst pharmacophore approach can also be used to generate common feature (HIPHOP) alignments [54] of the three molecules that active Ciona VDR/PXR. In this case the pharmacophore consisted of 1 hydrogen bond acceptor and 2 hydrophobic areas (Additional file 6). This pharmacophore is generally quite different compared with the models for other PXRs described above and in many ways reflects the very narrow substrate selectivity compared with the other six species.
###end p 42
###begin title 43
Phylogenetic analysis and ancestral reconstruction of NR1I receptors
###end title 43
###begin p 44
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Compared to other vertebrate NR subfamilies, the evolutionary history of the NR1I subfamily is difficult to reconstruct due to a high degree of functional and sequence divergence [10,12,22]. Some studies speculate that an ancestral gene duplicated early in vertebrate evolution (or possibly even prior to evolution of vertebrates), with subsequent divergence to become separate PXR and VDR genes [9,10,12,15,17,20,22,51]. Later in vertebrate evolution, a single PXR gene duplicated, with subsequent divergence to form separate PXR and CAR genes [10]. Throughout this manuscript, we follow the convention of designating the non-mammalian PXR/CAR-like genes as PXRs [12], although it is not certain that the ancestral PXR/CAR-like gene is actually the same gene now called PXR in mammals [9,10,20].
###end p 44
###begin p 45
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 445 452 <span type="species:ncbi:9031">chicken</span>
###xml 520 527 <span type="species:ncbi:9031">chicken</span>
Using 49 amino acid sequences of extant VDRs, PXRs, and CARs, we inferred phylogeny by maximum likelihood (Figure 4). Several clusters are clearly evident and supported by bootstrap analysis in the phylogeny presented in Figure 4: vertebrate VDRs, mammalian CARs, and mammalian PXRs. The major difficulty is the placement of the frog PXRs, which are quite different from other PXRs in function, tissue expression, and sequence [7,46,48,49]. The chicken PXR clusters with the CARs in Figure 4; however, by many measures, chicken PXR is equally related to mammalian CARs and PXRs [9,10,12].
###end p 45
###begin p 46
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 1099 1100 1099 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1648 1650 1648 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1651 1653 1651 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1665 1667 1665 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1688 1690 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1704 1706 1704 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1707 1709 1707 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1723 1725 1723 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1726 1728 1726 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1746 1748 1746 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1963 1964 1963 1964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 529 536 <span type="species:ncbi:9031">chicken</span>
###xml 1637 1642 <span type="species:ncbi:9606">human</span>
###xml 1656 1659 <span type="species:ncbi:10116">rat</span>
###xml 1673 1682 <span type="species:ncbi:7955">zebrafish</span>
###xml 1693 1698 <span type="species:ncbi:9606">human</span>
###xml 1712 1717 <span type="species:ncbi:9606">human</span>
###xml 1735 1740 <span type="species:ncbi:10090">mouse</span>
We also utilized maximum likelihood to infer the amino acid sequence of three 'ancestral' receptors, indicated as nodes in Figure 4 labelled as 'AncR1', 'AncR2', and 'AncR3' (Additional file 7). AncR1 represents the ancestral single receptor gene prior to duplication and subsequent divergence to VDRs and PXRs. AncR2 represents the PXR gene ancestral to the split between fish PXRs and mammalian CARs/PXRs. AncR3 represents the ancestral single receptor gene prior to duplication and subsequent divergence to mammalian PXRs and chicken PXR/mammalian CARs. It should be pointed out that ancestral reconstruction based on receptors that are markedly divergent in sequence, particularly when there are insertions or deletions of receptors relative to one another, is subject to significant uncertainly and should be interpreted cautiously. The inter-helical regions of the LBD are particularly difficult to predict. For the LBD, the percentage of amino acid residues with posterior probability greater than 0.7 is only 56.4%, 80.4%, and 65.0% in AncR1, AncR2, and AncR3, respectively (Additional file 7). These overall posterior probabilities are significantly lower than reconstruction of ancestral sex and mineralocortoid NRs (in the NR3 family) [55-57], where the cross-species sequence divergences are much less than for the NR1I subfamily of receptors. These uncertainties make homology modelling (or even functional expression) of the LBDs of reconstructed NR1I ancestral sequences unreliable. Therefore, we focused on cross-sequence comparisons of amino acid residues identified as interacting with ligands in crystal structures of human VDR [58-60], rat VDR [61,62], zebrafish VDR [63], human PXR [29-34], human CAR [64,65], and mouse CAR [66]. In this subset of 'ligand-binding residues', the percentage of amino acid residues with posterior probability greater than 0.7 is 56.8%, 90.2%, and 80.4% in AncR1, AncR2, and AncR3, respectively (Additional file 8); each of these values is higher than for the overall LBD sequence indicated above.
###end p 46
###begin p 47
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 186 201 186 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 288 289 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 347 348 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 402 408 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 620 621 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 642 643 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 715 717 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 744 750 737 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 851 857 844 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 1183 1184 1176 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1205 1206 1198 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 159 162 <span type="species:ncbi:10116">rat</span>
###xml 164 170 <span type="species:ncbi:9986">rabbit</span>
###xml 173 180 <span type="species:ncbi:9031">chicken</span>
###xml 186 200 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 223 232 <span type="species:ncbi:7955">zebrafish</span>
###xml 238 243 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 264 275 <span type="species:ncbi:7757">sea lamprey</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 953 962 <span type="species:ncbi:7955">zebrafish</span>
###xml 1030 1035 <span type="species:ncbi:9606">human</span>
###xml 1165 1170 <span type="species:ncbi:9606">human</span>
At the amino acid residue positions identified as ligand-binding residues, we compared Ciona VDR/PXR, AncR1, AncR2, and AncR3 to mammalian PXRs (human, mouse, rat, rabbit), chicken PXR, Xenopus laevis PXRalpha and PXRbeta, zebrafish PXR, human CAR, human VDR, and sea lamprey VDR (Figure 5). As with overall sequence comparisons in the LBD (Table 5), sequence identities at ligand-binding residues for Ciona VDR/PXR compared to the other receptors were overall low (< 25%). Interestingly, AncR1 showed the highest sequence identity to human VDR (64.7%); all other sequences were less than 51% identical to AncR1 (Figure 5 and Additional file 8). This would be consistent with VDR being the ancestral NR1I receptor [51]. The differences between Ciona VDR/PXR and AncR1 at the ligand-binding residue positions may be explained by rapid evolution of the Ciona gene, as discussed above. AncR2 had the highest sequence identity at ligand-binding residues to zebrafish PXR (56.9%), compared to ~ 45-50% for other PXRs and only 31.4% to human CAR. AncR3 had highest sequence identity at ligand-binding residues to mammalian PXRs (66.7% to 70.6%) compared to only 37.3% to human CAR (Figure 5 and Additional file 8). The results for AncR2 and AncR3 both suggest that CAR has diverged the most from the ancestral sequence at ligand-binding residues and would be consistent with PXR being the ancestral gene.
###end p 47
###begin p 48
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Conservation of ligand-binding residues</bold>
###xml 342 361 342 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 500 515 500 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 525 540 521 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 655 674 648 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 104 107 <span type="species:ncbi:10116">rat</span>
###xml 113 122 <span type="species:ncbi:7955">zebrafish</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 342 360 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 444 449 <span type="species:ncbi:9606">human</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
###xml 466 469 <span type="species:ncbi:10116">rat</span>
###xml 475 481 <span type="species:ncbi:9986">rabbit</span>
###xml 487 494 <span type="species:ncbi:9031">chicken</span>
###xml 500 514 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 525 539 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 549 558 <span type="species:ncbi:7955">zebrafish</span>
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 575 580 <span type="species:ncbi:9606">human</span>
###xml 590 601 <span type="species:ncbi:7757">sea lamprey</span>
###xml 655 673 <span type="species:ncbi:7719">Ciona intestinalis</span>
Conservation of ligand-binding residues. From published X-ray crystallographic structures of human VDR, rat VDR, zebrafish VDR, human PXR, human CAR, and mouse CAR (see Methods for references), amino acid residues that interact with ligands ('ligand-binding residues') were identified. At these amino acid residue positions, the sequences of Ciona intestinalis VDR/PXR, AncR1, AncR2, and AncR3 were compared with the corresponding sequence for human PXR, mouse PXR, rat PXR, rabbit PXR, chicken PXR, Xenopus laevis PXRalpha, Xenopus laevis PXRbeta, zebrafish PXR, human CAR, human VDR, and sea lamprey VDR. The ordinate represents the percent identity of Ciona intestinalis VDR/PXR, AncR1, AncR2, and AncR3 for the corresponding sequences of PXRs, VDRs, or CAR at these ligand-binding residue positions.
###end p 48
###begin title 49
Intrinsic disorder analysis
###end title 49
###begin p 50
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S10">10</xref>
###xml 806 807 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 812 814 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S10">10</xref>
###xml 1018 1019 1010 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1054 1060 1046 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 1129 1130 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 1135 1137 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S10">10</xref>
###xml 1311 1312 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S9">9</xref>
###xml 1317 1319 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S10">10</xref>
###xml 1574 1575 1566 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1576 1578 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1579 1581 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 538 544 <span type="species:ncbi:9986">Rabbit</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 637 642 <span type="species:ncbi:10090">mouse</span>
###xml 644 647 <span type="species:ncbi:10116">rat</span>
###xml 649 656 <span type="species:ncbi:9031">chicken</span>
###xml 662 671 <span type="species:ncbi:7955">zebrafish</span>
###xml 682 701 <span type="species:ncbi:8355">African clawed frog</span>
###xml 1144 1151 <span type="species:ncbi:9031">chicken</span>
###xml 1252 1259 <span type="species:ncbi:9031">chicken</span>
###xml 1400 1407 <span type="species:ncbi:9031">chicken</span>
###xml 1497 1504 <span type="species:ncbi:9031">chicken</span>
###xml 1596 1603 <span type="species:ncbi:9031">chicken</span>
A key factor in protein interactions with ligands or other proteins is presence of intrinsic structural disorder [67,68]. To assess whether disorder may account for pharmacological differences between the PXRs from different species, intrinsic disorder of the amino acid residues were predicted using the PONDR VL3H algorithm [68] and summarized by the percentage of residues with probability of disorder greater than 50%. Disorder probabilities were analyzed by domain (DBD or LBD) or total protein sequence (Additional files 9 and 10). Rabbit PXR was shown to possess lower predicted intrinsic disorder in the LBD compared with human, mouse, rat, chicken, and zebrafish PXRs. The African clawed frog PXRalpha (BXRalpha) had the lowest predicted intrinsic disorder in the LBD of any PXR (Additional files 9 and 10); as discussed above, this receptor has very restricted ligand specificity, essentially responding only to benzoates (and their close structural analogs) shown to be important in early frog development [7]. In terms of intrinsic disorder, Ciona VDR/PXR was closer to PXRs than to VDRs in the LBD (Additional files 9 and 10). The chicken PXR was distinct from the other PXRs in terms of low intrinsic disorder in the DBD; in this regard, chicken PXR is much more similar to CARs (Additional files 9 and 10). This is consistent with the hypothesis that an ancestral gene very similar to chicken PXR duplicated, with the two genes ultimately diverging into separate CAR and PXR genes (chicken PXR has about equal sequence similarity to mammalian CARs and PXRs) [9,10,12]. In the DBD, chicken PXR may have structural features more similar to mammalian CARs than PXRs. The results are consistent with differences in structural disorder possibly contributing to differences in pharmacologic specificity.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 373 382 373 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 776 785 776 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 476 481 <span type="species:ncbi:10090">mouse</span>
###xml 483 486 <span type="species:ncbi:10116">rat</span>
###xml 488 494 <span type="species:ncbi:9986">rabbit</span>
###xml 496 503 <span type="species:ncbi:9031">chicken</span>
###xml 509 518 <span type="species:ncbi:7955">zebrafish</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
###xml 602 605 <span type="species:ncbi:10116">rat</span>
###xml 673 682 <span type="species:ncbi:7955">zebrafish</span>
###xml 687 694 <span type="species:ncbi:9031">chicken</span>
###xml 848 857 <span type="species:ncbi:7955">zebrafish</span>
###xml 880 899 <span type="species:ncbi:8364">Western clawed frog</span>
###xml 940 959 <span type="species:ncbi:8355">African clawed frog</span>
PXRs show unusually low sequence conservation in the LBD across vertebrate species relative to other NRs [12,13,17]. Several groups have hypothesized that cross-species differences in the presence and utilization of endogenous and/or exogenous ligands have provided the evolutionary force for this divergence [8,15,69-71]. In this study, we have generated considerable new in vitro data that has enabled us to determine pharmacophore models for activation of six PXRs (human, mouse, rat, rabbit, chicken, and zebrafish) using a common set of 16 compounds. The pharmacophore models of human, mouse, and rat PXRs are quite similar overall, while the pharmacophore models for zebrafish and chicken PXRs are significantly different compared with those for the mammalian PXRs. The in vitro and modelling data support a smaller ligand-binding pocket for zebrafish PXR. Our data for the Western clawed frog PXR show that this receptor, similar to African clawed frog PXRs [7,49], may be sensitive only to benzoates and close analogs.
###end p 52
###begin p 53
###xml 49 68 49 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 95 111 95 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. intestinalis </italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 526 532 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 656 657 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 664 665 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 1188 1194 1188 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 49 67 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 95 110 <span type="species:ncbi:7719">C. intestinalis</span>
###xml 712 731 <span type="species:ncbi:8355">African clawed frog</span>
###xml 748 767 <span type="species:ncbi:8364">Western clawed frog</span>
We also report the first characterization of the Ciona intestinalis VDR/PXR. Sequencing of the C. intestinalis genome reveals only a single NR1I-like gene, along with two NR1H-like genes [19]. The Ciona 'VDR/PXR' has substantially less sequence identity in the LBD to either VDR or PXR than in the DBD, and the receptor was not activated by any of the steroids, bile salts, or vitamin D analogs tested. However, a planar ligand previously reported to activate AHRs, 6-formylindolo-[3,2-b]carbazole [72] robustly activated the Ciona VDR/PXR. Weaker activation was also achieved with two other planar ligands, carbamazepine (an anti-epilepsy medication) and n-butyl p-aminobenzoate (a compound that also activates African clawed frog PXRs [7,12,49], Western clawed frog PXR (this report), as well as several other PXRs [12]). A preliminary three-point pharmacophore indicates a relatively planar pharmacophore for Ciona VDR/PXR consisting of an off-center hydrogen bond acceptor flanked by two hydrophobic regions. This pharmacophore is different compared with those from the other six species described herein in that it is more restrictive. Intrinsic disorder analysis also suggests that Ciona VDR/PXR is more similar to PXR in the LBD than to VDR. The added disorder in the LBD (relative to VDR) may make it able to adapt to different ligands.
###end p 53
###begin p 54
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona</italic>
Our phylogenetic analysis, including reconstruction of ancestral sequences by maximum likelihood, is consistent with (although certainly does not prove) the hypothesis that VDR represents the ancestral NR1I gene [51,73]. Comparison of ligand-binding residue positions between extant and reconstructed ancestral sequences also suggests that PXR may represent the gene ancestral to extant mammalian CARs and PXRs. Identification of additional NR1I receptors in basal vertebrates, chordate invertebrates other than Ciona, reptiles, and basal mammals will be valuable in developing a more complete evolutionary history in future studies.
###end p 54
###begin p 55
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 594 600 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
These results are consistent with the natural ligands of Ciona VDR/PXR being markedly different than those of vertebrate VDRs or PXRs. It is perhaps noteworthy that the most potent and efficacious activator of Ciona VDR/PXR discovered in this study (6-formylindolo-[3,2-b]carbazole) is also a potent activator of vertebrate AHRs [72,74]. Studies of invertebrate AHRs reveal markedly different ligand selectivity compared to vertebrate AHRs [75] and also roles of the AHR system in invertebrate development [76,77]. Future studies will be aimed at identifying possible endogenous ligands of the Ciona VDR/PXR and other Ciona NRs; however, if the ligands for the Ciona receptor are exogenous, they may ultimately be difficult to uncover.
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 580 586 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 853 862 853 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 291 310 <span type="species:ncbi:8364">Western clawed frog</span>
###xml 407 416 <span type="species:ncbi:7955">zebrafish</span>
In contrast to other nuclear hormone receptors, we have demonstrated in vitro that PXRs show significant differences in ligand specificity across species. Further, by pharmacophore analysis, certain PXRs share similar molecular requirements, suggestive of functional overlap. The PXR of the Western clawed frog has diverged considerably in ligand selectivity from fish, bird, and mammalian PXRs. The LBD of zebrafish PXR is smaller than those of the mammals and is activated by a more limited range of compounds. Even more restricted is the small set of ligands found to activate Ciona VDR/PXR. Taken in sum, the ligand selectivity of PXR is surprisingly species dependent, and has undergone an ever expanding role in the progression of evolution from pre-chordates to fish to mammals and birds. The combined results suggest that using a combination of in vitro and computational methods we can qualitatively explain the unusual evolutionary history shaping the ligand selectivity of PXRs and this may be applicable to other proteins.
###end p 57
###begin title 58
Methods
###end title 58
###begin title 59
Chemicals
###end title 59
###begin p 60
###xml 46 47 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 512 527 476 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyprinus carpio</italic>
###xml 535 537 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 675 693 621 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aetobatus narinari</italic>
###xml 835 861 766 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alligator mississippiensis</italic>
###xml 506 510 <span type="species:ncbi:7962">carp</span>
###xml 512 527 <span type="species:ncbi:7962">Cyprinus carpio</span>
###xml 656 673 <span type="species:ncbi:87140">Spotted eagle ray</span>
###xml 675 693 <span type="species:ncbi:87140">Aetobatus narinari</span>
###xml 815 833 <span type="species:ncbi:8496">American alligator</span>
###xml 835 861 <span type="species:ncbi:8496">Alligator mississippiensis</span>
The sources of the chemicals were as follows: n-butyl-p-aminobenzoate, n-propyl-p-hydroxybenzoate, nifedipine, rifampicin (Sigma-Aldrich, St. Louis, MO, USA); 5alpha-cholanic acid-3alpha,7alpha,12alpha-triol (allocholic acid; Toronto Research Chemical, Inc., North York, ON, Canada); Nuclear Receptor Ligand Library (76 compounds known as ligands of various nuclear hormone receptors; BIOMOL). 5alpha-cyprinol sulfate (5alpha-cholestan-3alpha,7alpha,12alpha,26-tetrol-27-sulfate) was isolated from Asiatic carp (Cyprinus carpio) bile [78], 5beta-scymnol sulfate (5beta-cholestan-3alpha,7alpha,12alpha,24,26-pentol-27-sulfate) was isolated from the bile of Spotted eagle ray (Aetobatus narinari) bile, and 5beta-cholestan-3alpha,7alpha,12alpha-triol-27-oic acid, taurine conjugated was isolated from the bile of the American alligator (Alligator mississippiensis). Bile salts were purified by extraction and Flash column chromatography. Bile alcohol sulfates were chemically deconjugated using a solution of 2,2-dimethoxypropane:1.0 N HCl, 7:1 v/v, and incubating 2 hours at 37degreesC, followed by the addition of water and extraction into ether. Completeness of deconjugation and assessment of purity was performed by thin-layer chromatography using known standards. Other than those described above, steroids and bile salts were obtained from Steraloids (Newport, RI, USA).
###end p 60
###begin title 61
Animals
###end title 61
###begin p 62
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 0 18 <span type="species:ncbi:8364">Xenopus tropicalis</span>
Xenopus tropicalis frogs were obtained from NASCO (Fort Atkinson, WI, USA). All animal studies were performed in conformity with the Public Health Service Policy on Humane Care and Use of Laboratory Animals, incorporated in the Institute for Laboratory Animal Research Guide for Care and use of Laboratory Animals. All vertebrate animal studies were approved by the University of Pittsburgh Institutional Animal Care and Use Committees (approval number 0601348) or Committee on Animal Studies of the University of California, San Diego.
###end p 62
###begin title 63
Cloning and molecular biology
###end title 63
###begin p 64
###xml 11 30 11 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 668 674 668 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 11 29 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 31 50 <span type="species:ncbi:8364">Western clawed frog</span>
The LBD of Xenopus tropicalis (Western clawed frog) PXR (xtPXR) was cloned by PCR from RNA extracted from ovary of an adult female frog. Ciona VDR/PXR was cloned from cDNA fragments ciem829d05 and cilv048e18 provided by Professor Yuji Kohara (Center for Genetic Resource Information, National Institute of Genetics, Research Organization of Information and Systems, Mishima, Japan) and Professor Noriyuki Satoh (Kyoto University, Kyoto, Japan), with analysis of the cDNA clones supported by Grant-in-aid for Scientific Research on Priority Area "Genome" of Ministry of Education, Culture, Sports, Science and Technology, Japan. The LBD of xtPXR (residues 103-390) and Ciona VDR/PXR (residues 57-391) were inserted into the pM2-GAL4 vector to create a GAL4/LBD chimera suitable for study of ligand activation [17].
###end p 64
###begin title 65
Cell culture and functional assays
###end title 65
###begin p 66
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 468 483 464 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1006 1025 981 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 1575 1594 1547 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 1618 1624 1590 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 231 237 <span type="species:ncbi:9913">bovine</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
###xml 375 378 <span type="species:ncbi:10116">rat</span>
###xml 380 386 <span type="species:ncbi:9986">rabbit</span>
###xml 388 395 <span type="species:ncbi:9031">chicken</span>
###xml 409 416 <span type="species:ncbi:9031">chicken</span>
###xml 435 454 <span type="species:ncbi:8355">African clawed frog</span>
###xml 468 482 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 544 553 <span type="species:ncbi:7955">zebrafish</span>
###xml 874 879 <span type="species:ncbi:9606">human</span>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
###xml 888 891 <span type="species:ncbi:10116">rat</span>
###xml 893 899 <span type="species:ncbi:9986">rabbit</span>
###xml 905 912 <span type="species:ncbi:9031">chicken</span>
###xml 1006 1024 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 1034 1043 <span type="species:ncbi:7955">zebrafish</span>
###xml 1504 1509 <span type="species:ncbi:9606">human</span>
###xml 1511 1516 <span type="species:ncbi:10090">mouse</span>
###xml 1518 1524 <span type="species:ncbi:9986">rabbit</span>
###xml 1530 1533 <span type="species:ncbi:10116">rat</span>
###xml 1552 1559 <span type="species:ncbi:9031">chicken</span>
###xml 1575 1593 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 1599 1608 <span type="species:ncbi:7955">zebrafish</span>
The creation of a HepG2 (human liver) cell line stably expressing the human Na+-taurocholate cotransporter (NTCP) has been previously reported [17]. HepG2-NTCP cells were grown in modified Eagle's medium-alpha containing 10% fetal bovine serum and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA). Plasmids containing cDNAs for 8 PXRs from 7 species (human, mouse, rat, rabbit, chicken [also called chicken X receptor, CXR], African clawed frog [also termed Xenopus laevis benzoate X receptors alpha and beta, BXRalpha and BXRbeta ], zebrafish), as well as the reporter constructs tk-UAS-Luc and CYP3A4-PXRE-Luc, and 'empty' vectors pCDNA, PsG5, and PM2 were generously provided by SA Kliewer, JT Moore, and LB Moore (GlaxoSmithKline, Research Triangle Park, NC, USA). The expression vectors were either full-length receptors (i.e., containing both a DBD and LBD; human, mouse, rat, rabbit, and chicken PXRs) or GAL4/PXR chimeras that contain only the LBD of the PXR receptor (BXRalpha, BXRbeta, Xenopus tropicalis PXR, and zebrafish PXR). For the full-length expression vectors, the reporter plasmid was CYP3A4-PXRE-Luc, a construct that contains a promoter element from CYP3A4 (recognized by PXR DBDs) driving luciferase expression. For the GAL4/LBD expression constructs, the reporter plasmid was tk-UAS-Luc, which contains GAL4 DNA binding elements driving luciferase expression. The following transfection ratios of reporter, receptor, and beta-galactosidase plasmids were used (ng/well): human, mouse, rabbit, and rat PXRs - 25/2.7/20; chicken PXR - 10/1/20; Xenopus tropicalis PXR, zebrafish PXR, and Ciona VDR/PXR - 75/50/20.
###end p 66
###begin p 67
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 450 456 <span type="species:ncbi:9913">bovine</span>
The PXR activation assay was a luciferase-based reporter assay [17,45]. On day 1, 30,000 cells/well were seeded onto 96-well white opaque plates (Corning-Costar, Corning, NY, USA). On day 2, cells were transfected using the calcium phosphate precipitation method with expression vector or 'empty' control vector and luciferase reporter plasmid. On day 3, the cells were washed and then incubated with medium containing charcoal-dextran treated fetal bovine serum (Hyclone, Logan, UT, USA) and drugs or vehicle. On day 4, the cells were washed and the medium replaced with serum-free medium. Cells were washed with Hanks' buffered salt solution and then exposed to 150 muL lysis buffer (Reporter Lysis Buffer, Promega). Separate aliquots were taken for measurement of beta-galactosidase activity (Promega) and luciferase activity (Promega Steady-Glo luciferase assay).
###end p 67
###begin p 68
Activation of receptor by ligand was compared to receptor exposed to identical conditions without ligand ('vehicle control'). In general, dimethyl sulfoxide (Sigma) was used as vehicle and was adjusted to be 0.5% (v/v) in all wells. A control was also run with transfection of 'empty' vector (i.e., lacking the receptor cDNA) and reporter vector to control for activation of reporter vector by endogenous receptor(s). In experiments with a variety of activators, activation by endogenous receptors was not seen.
###end p 68
###begin p 69
###xml 649 668 626 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 674 675 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 683 684 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 764 770 731 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 807 808 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 1217 1224 1178 1185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">pooled </sub>
###xml 1230 1231 1191 1192 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1235 1236 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1236 1238 1197 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1242 1243 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1247 1248 1208 1209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1248 1250 1209 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1260 1261 1221 1222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">k</sub>
###xml 1265 1266 1226 1227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">k</sub>
###xml 1266 1267 1227 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1275 1279 1236 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1/2</sup>
###xml 1359 1362 1320 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
###xml 516 519 <span type="species:ncbi:10116">rat</span>
###xml 569 575 <span type="species:ncbi:9986">rabbit</span>
###xml 616 623 <span type="species:ncbi:9031">chicken</span>
###xml 649 667 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 709 718 <span type="species:ncbi:7955">zebrafish</span>
To facilitate more reliable cross-species comparisons, complete concentration-response curves for ligands were determined in the same microplate as determination of response to a maximal activator. This allows for determination of relative efficacy, epsilon defined as the maximal response to test ligand divided by maximal response to a reference maximal activator (note than epsilon can exceed 1). The following maximal activators and their concentrations were as follows: human PXR - 10 muM rifampicin; mouse and rat PXRs - 10 muM pregnenolone 16alpha-carbonitrile; rabbit PXR - 50 muM 5beta-pregnane-3,20-dione; chicken PXR - 20 muM nifedipine; Xenopus tropicalis PXR - n-propyl-p-hydroxybenzoate 50 muM; zebrafish PXR - 20 muM 5alpha-androstan-3alpha-ol; and Ciona VDR/PXR - 20 muM 6-formylindolo-[3,2-b]carbazole. All comparisons to maximal activators were done within the same microplate. Luciferase data were normalized to the internal beta-galactosidase control and represent means +/- SD of the assays. Concentration-response curves were fitted using Kaleidagraph software (Synergy Software, Reading, PA, USA). In combining data from multiple experiments, the pooled variance was calculated by the formula spooled = {[(n1-1)s12 + (n2-1)s22 + ... + (nk-1)sk2]/[N-k]}-1/2, where there are N total data points among k groups, with n replicates in the ith group.
###end p 69
###begin title 70
Toxicity assays in HepG2 cells
###end title 70
###begin p 71
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
To test for cytotoxicity, two assays that have been well-validated in HepG2 cells were used: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction and alamar blue reduction. Both assays sensitively measure the ability of viable cells to metabolize the parent compound to a metabolite that can be detected by spectrophotometry or fluorometry [79]. HepG2 cells were seeded at a density of 20,000 cells/well (100 muL per well) into clear 96-well microplates (for the MTT assay) or black, opaque 96-well plates (for the alamar blue assay) and grown for 24 hours. The next day, 100 muL solutions of drug concentrations or vehicle controls in cell growth medium at twice the intended final concentration were added to the cells (final volume 200 muL). The cells were again incubated for 24 hr. For the MTT assays, MTT (In vitro toxicology assay kit, MTT-based; Sigma, St. Louis, MO, USA) was dissolved at 5 mg/mL in warm cell growth medium. 20 muL of this solution was added to the cells (total volume 220 muL), and the plates incubated for another 4 hrs. After incubation, the supernatant was removed and 50 muL of solubilization buffer provided in the Sigma kit with 0.5% DMSO was added. DMSO was added to ensure total solubility of the formazan crystals. Plates were shaken for 2 min, and the absorbance recorded at 590 nm. The percent viability was expressed as absorbance in the presence of test compound as a percentage of that in the vehicle control (with subtraction of background absorbance).
###end p 71
###begin p 72
For the alamar blue assays, alamar blue stock solution (Biosource International; Camarillo, CA, USA) was diluted 1:1 with cell growth medium and 50 muL of this was added to each well, yielding a final concentration of 10% alamar blue (total volume 250 muL). The plates were exposed to an excitation wavelength of 530 nm, and the emission at 590 nm was recorded to determine whether any of the test drug concentrations fluoresce at the emission wavelength. Plates were returned to the incubator for 5 hr and the fluorescence was measured again. The percent viability was expressed as fluorescence counts in the presence of test compound as a percentage of that in the vehicle control (with subtraction of background fluorescence). Drug concentrations that cause > 30% loss of cell viability in the MTT assay or > 15% loss of cell viability in the alamar blue assay were not used in the determination of concentration-response curves for activation of PXRs.
###end p 72
###begin title 73
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
In silico modelling - Catalysttrade mark
###end title 73
###begin p 74
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 779 780 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 807 817 780 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">bold type </bold>
###xml 928 931 901 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
Pharmacophore modelling was performed as described previously [45,54]. Briefly, computational molecular modeling studies were carried out using Discovery Studio 1.7 Catalysttrade mark (Accelrys, San Diego, CA) running on a Sony Vaio with Intel Centrino processor. Pharmacophore models attempt to describe the arrangement of key features that are important for biological activity. Briefly, the Catalysttrade mark models were employed to generate hypotheses. Molecules were imported from sdf files, the 3-D molecular structures were produced using up to 255 conformers with the Best conformer generation method, allowing a maximum energy difference of 20 kcal/mol. Hypogen PXR pharmacophores for each species were generated with Catalysttrade mark using the 16 molecules in Table 4. Molecules highlighted in bold type were used for training as they are common to all species - molecules with no effect were given the arbitrary EC50 value of 10,000 muM (10 mM).
###end p 74
###begin p 75
###xml 89 92 89 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 583 585 583 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r </italic>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 680 681 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 757 763 757 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
Ten hypotheses were generated using these conformers for each of the molecules and the EC50 values, after selection of the following features: hydrophobic, hydrogen bond acceptor, and hydrogen bond donor with up to 4 excluded volumes. After assessing all ten generated hypotheses, the hypothesis with the lowest energy cost was selected for further analysis as this possessed features representative of all the hypotheses and had the lowest total cost. The quality of the structure activity correlation between the estimated and observed activity values was estimated by means of an r value. Additionally 6-formylindolo-[3,2-b]carbazole was aligned with carbamazepine and n-butyl-p-aminobenzoate with the HIPHOP alignment to ascertain the pharmacophore for Ciona VDR/PXR.
###end p 75
###begin title 76
Phylogenetic analysis and ancestral sequence reconstruction
###end title 76
###begin p 77
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 439 454 439 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 488 499 488 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmo salar</italic>
###xml 577 599 577 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Paralichthys olivaceus</italic>
###xml 704 725 704 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gastrosteus aculeatus</italic>
###xml 790 809 790 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 1024 1038 1024 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phoca sibirica</italic>
###xml 1076 1095 1076 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Callorhinus ursinus</italic>
###xml 1476 1491 1476 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1513 1528 1509 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1549 1568 1542 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 1685 1708 1678 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetraodon nigriviridis </italic>
###xml 1798 1809 1791 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bombyx mori</italic>
###xml 1855 1875 1848 1868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amblyomma americanum</italic>
###xml 1931 1960 1924 1953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Strongylocentrotus purpuratus</italic>
###xml 2031 2033 2024 2026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 2057 2059 2050 2052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
###xml 170 180 <span type="species:ncbi:9598">chimpanzee</span>
###xml 215 228 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 263 266 <span type="species:ncbi:9913">cow</span>
###xml 301 304 <span type="species:ncbi:9615">dog</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 361 364 <span type="species:ncbi:10116">rat</span>
###xml 382 389 <span type="species:ncbi:9031">chicken</span>
###xml 407 421 <span type="species:ncbi:93934">Japanese quail</span>
###xml 439 453 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 471 486 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 488 499 <span type="species:ncbi:8030">Salmo salar</span>
###xml 560 575 <span type="species:ncbi:8255">bastard halibut</span>
###xml 577 599 <span type="species:ncbi:8255">Paralichthys olivaceus</span>
###xml 618 627 <span type="species:ncbi:7955">zebrafish</span>
###xml 645 651 <span type="species:ncbi:8090">medaka</span>
###xml 761 772 <span type="species:ncbi:7757">sea lamprey</span>
###xml 790 808 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 830 835 <span type="species:ncbi:9606">human</span>
###xml 853 863 <span type="species:ncbi:9598">chimpanzee</span>
###xml 914 917 <span type="species:ncbi:9913">cow</span>
###xml 952 955 <span type="species:ncbi:9615">dog</span>
###xml 990 993 <span type="species:ncbi:9823">pig</span>
###xml 1011 1022 <span type="species:ncbi:9719">Baikal seal</span>
###xml 1024 1038 <span type="species:ncbi:9719">Phoca sibirica</span>
###xml 1057 1074 <span type="species:ncbi:34884">Northern fur seal</span>
###xml 1076 1095 <span type="species:ncbi:34884">Callorhinus ursinus</span>
###xml 1114 1119 <span type="species:ncbi:10090">mouse</span>
###xml 1137 1140 <span type="species:ncbi:10116">rat</span>
###xml 1158 1161 <span type="species:ncbi:9823">pig</span>
###xml 1221 1226 <span type="species:ncbi:9606">human</span>
###xml 1244 1254 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1281 1294 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 1312 1315 <span type="species:ncbi:9913">cow</span>
###xml 1350 1355 <span type="species:ncbi:10090">mouse</span>
###xml 1364 1367 <span type="species:ncbi:10116">rat</span>
###xml 1385 1391 <span type="species:ncbi:9986">rabbit</span>
###xml 1451 1458 <span type="species:ncbi:9031">chicken</span>
###xml 1476 1490 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 1513 1527 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 1549 1567 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 1644 1650 <span type="species:ncbi:8090">medaka</span>
###xml 1741 1750 <span type="species:ncbi:7955">zebrafish</span>
###xml 1779 1796 <span type="species:ncbi:7091">domestic silkworm</span>
###xml 1798 1809 <span type="species:ncbi:7091">Bombyx mori</span>
###xml 1855 1875 <span type="species:ncbi:6943">Amblyomma americanum</span>
###xml 1912 1929 <span type="species:ncbi:7668">purple sea urchin</span>
###xml 1931 1960 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
The following sequences were used for phylogenetic analysis and ancestral sequence reconstruction (some links are from the Ensembl database [80]): human VDR [GenBank: ], chimpanzee VDR [Ensembl:ENSPTRT00000009010], rhesus monkey VDR [Ensembl:ENSMMUT00000009414], cow VDR [Ensembl:ENSBTAT00000021832], dog VDR [Ensembl:ENCAFT00000014497], mouse VDR [GenBank: ], rat VDR [GenBank: ], chicken VDR [GenBank: ], Japanese quail VDR [GenBank: ], Xenopus laevis VDR [GenBank: ], Atlantic salmon (Salmo salar) VDR [GenBank: ], fugu VDR [Ensembl:NEWSINFRUT00000138841], bastard halibut (Paralichthys olivaceus) VDR [GenBank: ], zebrafish VDR [GenBank: ], medaka VDR [Ensembl:ENSORLT00000001311], stickleback fish (Gastrosteus aculeatus) VDR [Ensembl:ENSGACT00000006308], sea lamprey VDR [GenBank: ], Ciona intestinalis VDR/PXR [GenBank: ], human CAR [GenBank: ], chimpanzee CAR [ENSPTRT00000002884], rhesus CAR [GenBank: ], cow CAR [Ensembl:ENSBTAT00000012145], dog CAR [Ensembl:ENSCAFT00000020528], pig CAR [GenBank: ], Baikal seal (Phoca sibirica) CAR [GenBank: ], Northern fur seal (Callorhinus ursinus) CAR [GenBank: ], mouse CAR [GenBank: ], rat CAR [GenBank: ], pig CAR [GenBank: ], opossum CAR [Ensembl:ENSMODT00000006393], human PXR [GenBank: ], chimpanzee PXR [ENSPTRT00000028510], rhesus monkey PXR [GenBank: ], cow PXR [Ensembl:ENSBTAT00000026059], mouse PXR [], rat PXR [GenBank: ], rabbit PXR [GenBank: ], opossum PXR [Ensembl:ENSMODT00000023109], chicken PXR [GenBank: ], Xenopus laevis PXRalpha [GenBank: ], Xenopus laevis PXRbeta [GenBank: ], Xenopus tropicalis PXR [Ensembl:ENSXETT00000039109], fugu PXR [Ensembl:NEWSINFRUT00000171584], medaka PXR [Ensembl:ENSORLT00000022473], Tetraodon nigriviridis PXR [Ensembl:GSTENT00026021001], zebrafish PXR [GenBank: , GenBank: ], domestic silkworm (Bombyx mori) ecdysone receptor [GenBank: ], ixotid tick (Amblyomma americanum) ecdysone receptor [GenBank: ], and purple sea urchin (Strongylocentrotus purpuratus) liver X receptor [GenBank: ]. Sequences were aligned using ClustalW [81] and Tcoffee software [82] and manually adjusted as needed.
###end p 77
###begin p 78
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 899 900 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 905 906 905 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 722 727 <span type="species:ncbi:9606">human</span>
###xml 741 744 <span type="species:ncbi:10116">rat</span>
###xml 758 767 <span type="species:ncbi:7955">zebrafish</span>
###xml 778 783 <span type="species:ncbi:9606">human</span>
###xml 797 802 <span type="species:ncbi:9606">human</span>
###xml 820 825 <span type="species:ncbi:10090">mouse</span>
Phylogeny was inferred by maximum likelihood using PHYML software [83,84], assuming a WAG protein model and a 4-category discrete gamma distribution of among-site rate variation. To estimate support, 100 bootstrap replicates were analyzed. Ancestral protein sequences of AncR1, AncR2, and AncR3 (see nodes in Figure 4) were inferred by maximum likelihood using PAML 3.15 software [85,86] on the maximum likelihood phylogeny of 49 amino acid sequences of extant VDRs, PXRs, and CARs (see Figure 4). For ancestral reconstruction, the JTT+G model (supported with 100% posterior probability in the Bayesian analysis) was assumed. Residues that interacted closely with ligands in published X-ray crystallographic structures of human VDR [58-60], rat VDR [61,62], zebrafish VDR [63], human PXR [29-34], human CAR [64,65], and mouse CAR [66] were identified and designated in Figure 5 and Additional files 7 and 8 as 'ligand-binding residues'.
###end p 78
###begin title 79
Calculation of protein structural disorder
###end title 79
###begin p 80
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S10">10</xref>
Intrinsic disorder prediction of protein sequences were performed using the PONDR VL3H algorithm [68,87]. The disorder calculations for each amino acid residue are available as Additional file 10.
###end p 80
###begin title 81
Abbreviations
###end title 81
###begin p 82
###xml 65 72 <span type="species:ncbi:9031">chicken</span>
Benzoate X receptor, BXR; constitutive androstane receptor, CAR; chicken X receptor, CXR; DNA-binding domain, DBD; ligand-binding domain, LBD; nuclear hormone receptor, NR; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, MTT; pregnane X receptor, PXR; 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD; vitamin D receptor, VDR.
###end p 82
###begin title 83
Authors' contributions
###end title 83
###begin p 84
SE performed the molecular modeling and protein disorder studies and helped draft the manuscript. EJR performed the molecular biology and assisted with the functional assays. LRH purified bile salts from animal bile to use as PXR ligands. MDK conceived of the study, performed most of the functional assays, and drafted the manuscript. All authors contributed to, read, and approved the final manuscript.
###end p 84
###begin title 85
Supplementary Material
###end title 85
###begin title 86
Additional file 1
###end title 86
###begin p 87
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 136 155 136 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 136 154 <span type="species:ncbi:7719">Ciona intestinalis</span>
Sequence alignment of nine PXRs and the Ciona VDR/PXR. Sequence alignment of the DNA-binding and ligand-binding domains of PXRs and the Ciona intestinalis VDR/PXR
###end p 87
###begin p 88
Click here for file
###end p 88
###begin title 89
Additional file 2
###end title 89
###begin p 90
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
###xml 126 131 <span type="species:ncbi:9606">human</span>
###xml 136 145 <span type="species:ncbi:7955">zebrafish</span>
Table of activation data for human and zebrafish PXRs by bile salts. Summary of concentration-response data for activation of human and zebrafish PXRs by bile salts
###end p 90
###begin p 91
Click here for file
###end p 91
###begin title 92
Additional file 3
###end title 92
###begin p 93
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 48 57 <span type="species:ncbi:7955">zebrafish</span>
###xml 111 117 <span type="species:ncbi:9606">humans</span>
###xml 122 131 <span type="species:ncbi:7955">zebrafish</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 198 207 <span type="species:ncbi:7955">zebrafish</span>
Comparison of bile salt activation of human and zebrafish PXRs. Comparison of bile salt synthetic pathways for humans and zebrafish, indicating which bile salts and intermediates activate human and zebrafish PXRs.
###end p 93
###begin p 94
Click here for file
###end p 94
###begin title 95
Additional file 4
###end title 95
###begin p 96
Table summary of statistics of the pharmacophore models. Summary of the statistics for the pharmacophore models of activation of PXRs.
###end p 96
###begin p 97
Click here for file
###end p 97
###begin title 98
Additional file 5
###end title 98
###begin p 99
###xml 35 54 35 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 63 82 63 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 176 195 176 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 20 29 <span type="species:ncbi:7955">zebrafish</span>
###xml 35 53 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 63 81 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 161 170 <span type="species:ncbi:7955">zebrafish</span>
###xml 176 194 <span type="species:ncbi:8364">Xenopus tropicalis</span>
Additional data for zebrafish PXR, Xenopus tropicalis PXR, and Ciona intestinalis VDR/PXR. Summary of data for screening of compounds as possible activators for zebrafish PXR, Xenopus tropicalis PXR, and the Ciona VDR/PXR.
###end p 99
###begin p 100
Click here for file
###end p 100
###begin title 101
Additional file 6
###end title 101
###begin p 102
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona </italic>
HIPHOP model for Ciona VDR/PXR. HIPHOP alignment of carbamazepine, 6-formylindolo-[3,2-b]carbazole, and n-butyl-p-aminobenzoate as activators of Ciona VDR/PXR.
###end p 102
###begin p 103
Click here for file
###end p 103
###begin title 104
Additional file 7
###end title 104
###begin p 105
Reconstructed ancestral sequences. Detailed data for the reconstruction of ancestral sequences.
###end p 105
###begin p 106
Click here for file
###end p 106
###begin title 107
Additional file 8
###end title 107
###begin p 108
Comparison of ligand-binding residues between extant and reconstructed sequences. Conservation of ligand-binding residues in extant and reconstructed PXR sequences.
###end p 108
###begin p 109
Click here for file
###end p 109
###begin title 110
Additional file 9
###end title 110
###begin p 111
Intrinsic disorder summary for PXRs, VDRs, and CARs. Summary data for intrinsic disorder predictions for PXR, VDR, and CAR sequences.
###end p 111
###begin p 112
Click here for file
###end p 112
###begin title 113
Additional file 10
###end title 113
###begin p 114
Intrinsic disorder data for PXRs, VDRs, and CARs. Intrinsic disorder data for each amino acid residue of PXR, VDR, and CAR sequences analyzed.
###end p 114
###begin p 115
Click here for file
###end p 115
###begin title 116
Acknowledgements
###end title 116
###begin p 117
###xml 431 450 431 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ciona intestinalis </italic>
###xml 431 449 <span type="species:ncbi:7719">Ciona intestinalis</span>
MDK is supported by K08-GM074238 from the National Institutes of Health and the Competitive Medical Research Fund from the University of Pittsburgh Medical Center. The authors also acknowledge Professor Yuji Kohara (Center for Genetic Resource Information, National Institute of Genetics, Research Organization of Information and Systems, Mishima, Japan) and Professor Noriyuki Satoh (Kyoto University, Kyoto, Japan) for providing Ciona intestinalis cDNA clones, supported by Grant-in-aid for Scientific Research on Priority Area "Genome" of Ministry of Education, Culture, Sports, Science and Technology, Japan. SE gratefully acknowledges Dr. David Lawson for initial advice on intrinsic disorder prediction and Accelrys for access to Discovery Studio Catalyst.
###end p 117
###begin article-title 118
###xml 20 25 <span type="species:ncbi:9606">human</span>
Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction
###end article-title 118
###begin article-title 119
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
###end article-title 119
###begin article-title 120
Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor
###end article-title 120
###begin article-title 121
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution
###end article-title 121
###begin article-title 122
###xml 53 62 <span type="species:ncbi:7955">zebrafish</span>
Expression of PXR, CYP3A, and MDR1 genes in liver of zebrafish
###end article-title 122
###begin article-title 123
###xml 90 99 <span type="species:ncbi:7955">zebrafish</span>
###xml 101 112 <span type="species:ncbi:7955">Danio rerio</span>
Cloning and identification of a full length pregnane X receptor and expression in vivo in zebrafish (Danio rerio)
###end article-title 123
###begin article-title 124
BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites
###end article-title 124
###begin article-title 125
SXR, a novel steroid and xenobiotic-sensing nuclear receptor
###end article-title 125
###begin article-title 126
###xml 7 14 <span type="species:ncbi:9031">chicken</span>
CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR)
###end article-title 126
###begin article-title 127
The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals
###end article-title 127
###begin article-title 128
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
###end article-title 128
###begin article-title 129
Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors
###end article-title 129
###begin article-title 130
###xml 113 116 <span type="species:ncbi:10116">rat</span>
Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome
###end article-title 130
###begin article-title 131
Functional evolution of the pregnane X receptor
###end article-title 131
###begin article-title 132
Evolution of the pregnane X receptor: adaptation to cross-species differences in biliary bile salts
###end article-title 132
###begin article-title 133
###xml 62 84 <span type="species:ncbi:99883">Tetraodon nigroviridis</span>
Genome inventory and analysis of nuclear hormone receptors in Tetraodon nigroviridis
###end article-title 133
###begin article-title 134
Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors)
###end article-title 134
###begin article-title 135
###xml 20 38 <span type="species:ncbi:7719">Ciona intestinalis</span>
The draft genome of Ciona intestinalis: insights into vertebrate origins
###end article-title 135
###begin article-title 136
###xml 57 75 <span type="species:ncbi:7719">Ciona intestinalis</span>
A genomewide survey of developmentally relevant genes in Ciona intestinalis. III. Genes for Fox, ETS, nuclear receptors and NFkB
###end article-title 136
###begin article-title 137
Evolutionary genomics of nuclear receptors: from twenty-five ancestral genes to derived endocrine systems
###end article-title 137
###begin article-title 138
###xml 72 101 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
The chemical defensome: environmental sensing and response genes in the Strongylocentrotus purpuratus genome
###end article-title 138
###begin article-title 139
Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds
###end article-title 139
###begin article-title 140
###xml 24 31 <span type="species:ncbi:71164">hagfish</span>
Analysis of lamprey and hagfish genes reveals a complex history of gene duplications during early vertebrate evolution
###end article-title 140
###begin article-title 141
Tunicates and not cephalochordates are the closest living relatives of vertebrates
###end article-title 141
###begin article-title 142
###xml 18 36 <span type="species:ncbi:7719">Ciona intestinalis</span>
Ghost database of Ciona intestinalis Genomics and cDNA resources
###end article-title 142
###begin article-title 143
A phylogenetic survey of biliary lipids in vertebrates
###end article-title 143
###begin article-title 144
###xml 82 89 <span type="species:ncbi:71164">hagfish</span>
Comparative studies of bile salts. Myxinol disulphate, the principal bile salt of hagfish (Myxinidae)
###end article-title 144
###begin article-title 145
Bile salt evolution
###end article-title 145
###begin article-title 146
###xml 27 32 <span type="species:ncbi:9606">human</span>
2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin
###end article-title 146
###begin article-title 147
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity
###end article-title 147
###begin article-title 148
Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor
###end article-title 148
###begin article-title 149
Crystal structure of PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism
###end article-title 149
###begin article-title 150
Crystal structure of PXR-estradiol complex provides insights into endobiotic recognition
###end article-title 150
###begin article-title 151
###xml 38 43 <span type="species:ncbi:9606">human</span>
Structural disorder in the complex of human PXR and the macrolide antibiotic rifampicin
###end article-title 151
###begin article-title 152
Bile acids: natural ligands for an orphan nuclear receptor
###end article-title 152
###begin article-title 153
Endogenous bile acids are ligand for the nuclear receptor FXR/BAR
###end article-title 153
###begin article-title 154
Identification of a nuclear receptor for bile acids
###end article-title 154
###begin article-title 155
Vitamin D receptor as an intestinal bile acid sensor
###end article-title 155
###begin article-title 156
5a-Bile alcohols function as farnesoid X receptor antagonists
###end article-title 156
###begin article-title 157
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
###end article-title 157
###begin article-title 158
Structural determinants for vitamin D responses to endocrine and xenobiotic signals
###end article-title 158
###begin article-title 159
PXR and the regulation of apoA1 and HDL-cholesterol in rodents
###end article-title 159
###begin article-title 160
###xml 20 25 <span type="species:ncbi:9606">human</span>
A pharmacophore for human pregnane X receptor ligands
###end article-title 160
###begin article-title 161
The identification of ligand features essential for PXR activation
###end article-title 161
###begin article-title 162
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites
###end article-title 162
###begin article-title 163
Molecular cloning and functional characterization of a novel nuclear receptor similar to an embryonic benzoate receptor BXR
###end article-title 163
###begin article-title 164
###xml 53 67 <span type="species:ncbi:8355">Xenopus laevis</span>
Evolution of duplicate genes in a tetraploid animal, Xenopus laevis
###end article-title 164
###begin article-title 165
Expression pattern of BXR suggests a role for benzoate ligand-mediated signalling in hatching gland function
###end article-title 165
###begin article-title 166
Benzoate X receptors a and b are pharmacologically distinct and do not function as xenobiotic receptors
###end article-title 166
###begin article-title 167
###xml 78 92 <span type="species:ncbi:8355">Xenopus laevis</span>
ARNT gene multiplicity in amphibians: characterization of ARNT2 from the frog Xenopus laevis
###end article-title 167
###begin article-title 168
Functional evolution of the vitamin D and pregnane X receptors
###end article-title 168
###begin article-title 169
###xml 4 22 <span type="species:ncbi:7719">Ciona intestinalis</span>
The Ciona intestinalis genome: when the constraints are off
###end article-title 169
###begin article-title 170
###xml 52 70 <span type="species:ncbi:7719">Ciona intestinalis</span>
Loss of ancestral genes in the genomic evolution of Ciona intestinalis
###end article-title 170
###begin article-title 171
A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRa, and LXRb
###end article-title 171
###begin article-title 172
Evolution of hormone-receptor complexity by molecular exploitation
###end article-title 172
###begin article-title 173
Crystal structure of an ancient protein: evolution by conformational epistasis
###end article-title 173
###begin article-title 174
Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling
###end article-title 174
###begin article-title 175
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
###end article-title 175
###begin article-title 176
Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands
###end article-title 176
###begin article-title 177
Crystal structure of the vitamin D receptor liganded with the vitamin D side chain analogues calicotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by a further side chain modification
###end article-title 177
###begin article-title 178
###xml 27 30 <span type="species:ncbi:10116">rat</span>
Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide
###end article-title 178
###begin article-title 179
New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations
###end article-title 179
###begin article-title 180
Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation
###end article-title 180
###begin article-title 181
The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization
###end article-title 181
###begin article-title 182
###xml 52 57 <span type="species:ncbi:9606">human</span>
A structural basis for constitutive activity in the human CAR/RXRa heterodimer
###end article-title 182
###begin article-title 183
###xml 17 23 <span type="species:ncbi:10090">murine</span>
Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism
###end article-title 183
###begin article-title 184
Flexible nets: the roles of intrinsic disorder in protein interaction networks
###end article-title 184
###begin article-title 185
Optimizing long intrinsic disorder predictors with protein evolutionary information
###end article-title 185
###begin article-title 186
The nuclear pregnane X receptor regulates xenobiotic detoxification
###end article-title 186
###begin article-title 187
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450
###end article-title 187
###begin article-title 188
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
###end article-title 188
###begin article-title 189
Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances
###end article-title 189
###begin article-title 190
###xml 61 79 <span type="species:ncbi:7757">Petromyzon marinus</span>
Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth
###end article-title 190
###begin article-title 191
Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity
###end article-title 191
###begin article-title 192
Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics
###end article-title 192
###begin article-title 193
The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems
###end article-title 193
###begin article-title 194
###xml 92 99 <span type="species:ncbi:9031">chicken</span>
Cytochrome P450 1 genes in early deuterostomes (tunicates and sea urchins) and vertebrates (chicken and frog): origin and diversification of the CYP1 gene family
###end article-title 194
###begin article-title 195
Physicochemical and physiological properties of 5a-cyprinol sulfate, the toxic bile salt of cyprinid fish
###end article-title 195
###begin article-title 196
Comparison of alamar blue and MTT assays for high through-put screening
###end article-title 196
###begin article-title 197
Ensembl database
###end article-title 197
###begin article-title 198
ClustalW server
###end article-title 198
###begin article-title 199
Tcoffee server
###end article-title 199
###begin article-title 200
PHYML - a simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood
###end article-title 200
###begin article-title 201
PHYML online - a web server for fast maximum likelihood-based phylogenetic inference
###end article-title 201
###begin article-title 202
A new method for inference of ancestral nucleotide and amino acid sequences
###end article-title 202
###begin article-title 203
PAML: a program package for phylogenetic analysis by maximum likelihood
###end article-title 203
###begin article-title 204
PONDR VL3H algorithm
###end article-title 204

